Indeed, in the study of cross-talk between the molecular pathways involved in CRC onset and progression or therapeutical resistance, the use of commercial over home-made media containing RSPO1 should be preferred as it did not exacerbate the negative feedback involving Wnt and mTOR. The gene discussed is MTOR; the disease is colorectal carcinoma.